We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Presents Data on Delayed Diabetes Drug Galvus
Novartis Presents Data on Delayed Diabetes Drug Galvus
September 17, 2007
Patients with uncontrolled Type 2 diabetes treated with metformin were four times more likely to achieve recommended blood sugar control levels by adding Galvus to their treatment regimen compared to those who added a placebo, according to new clinical data Novartis announced this week.